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Background: Aortic aneurysm (AA) is one of the most common causes of sud-
den death among elderly people. Although AA can be detected by non-invasive 
imaging techniques, there are no pharmacological treatments currently available 
to prevent progression at any stage of the disease. In this study we will explore 
the expression of inhibitor of nuclear factor kappa-B kinase epsilon (IKKe) in AA 
and its potential underlying molecular mechanism in AA. 
Materials and methods: Human aortic tissue was taken from 14 patients who 
underwent surgical repair of AA for the AA group and another 11 patients with 
normal aorta who underwent aortic valve replacement surgery for the control 
group. After excision, we used haematoxylin-eosin staining, Masson staining, 
immunohistochemistry analysis and Western blot analysis to observe the expres-
sion, location and morphological changes of the IKKe, P50 and the extracellular 
matrix within the AA. 
Results: In the AA group, haematoxylin-eosin staining revealed a loss of me-
dial integrity and inflammatory cell infiltration. Masson staining confirmed the 
degradation of the extracellular matrix in the AA group. Immunohistochemistry 
analysis showed increased infiltration of inflammatory cells and up-regulation 
of proinflammatory cytokines in the AA group when compared to the control 
group. Based on immunohistochemistry and Western blot analysis, there was 
clearly over-expression of IKKe, P50 and MMP2 in AA group, mainly in the intrinsic 
aortic cells of the media.
Conclusions: The over-expression of IKKe may play an important role in the ori-
gination and progression of AA and might be a vital target for their treatment. 
(Folia Morphol 2017; 76, 3: 372–378)
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INTRODUCTION
Aortic aneurysm (AA) is a degenerative disease of the 
aorta with a natural history of progressive dilation and 
rupture. In the past decade, AA have been detected using 
colour Doppler, multislice spiral computed tomography 
angiography (MCSTA) and digital subtraction angio- 
graphy, but no pharmacological therapy can limit their 
progression or prevent their rupture [16]. AA are char-
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acterised by the medial degeneration, and investigations 
of the pathogenesis of AA focus mainly on the effects 
of hypertension, age, and apoptotic pathway activa-
tion, which finally results in the apoptosis of smooth 
muscle cells and degradation of the extracellular matrix 
[11, 15]. Hinterseher et al. [4] showed that gene such as 
GATM, FOSB, ADCY7 and proteins such as CXCR4, PLEK, 
and GATM participated in the development of AA using 
a custom-designed “AA-chip”, Western blot and immuno-
histochemical staining. However, the precise underlying 
aetiology of AA remains unclear.
A recent study showed that inhibitor of nuclear 
factor kappa-B kinase epsilon (IKKe) is related to vas-
cular inflammation, which accounts for its important 
role in the atherosclerosis, and it also has a potential 
relationship with the hypertension [13]. The role of 
IKKe in the development of atherosclerosis was further 
verified in our previous investigation, and recent stud-
ies have confirmed that atherosclerosis is a risk factor 
for AA [1, 6, 13]. Matrix metalloproteinase-2 (MMP-2), 
a downstream of IKKe, is widespread and responsible 
for extracellular collagen degradation and remodel-
ling [8]. Therefore, we assumed that IKKe might play 
a role in the development and progression of AA.
In this study, we examined the activation of IKKe 
and its related downstream factors in aortic tissues 
from the patients in the aortic aneurysm group and 
the control group, to observe whether IKKe has an 
underlying role in AA.
MATERIALS AND METHODS
Patient enrolment and aortic specimen collection 
The study conforms to the principles outlined in 
the Declaration of Helsinki. The trial was approved 
by the ethics committee of Nanjing Medical Univer-
sity affiliated Nanjing First Hospital and each patient 
provided written informed consent. Between 2011 
and 2013, 102 patients were admitted to in Nanjing 
First Hospital for the treatment of the AA. Patients 
meeting the criteria for the study were then divided 
into one of the groups (AA group and control group). 
We randomly selected 14 patients who underwent 
open surgical repair of AA to avoid bias for the AA 
group and another 11 patients who underwent aortic 
valve replacement surgery with normal aortas for 
the control group. Patients were excluded if they 
had a history of heritable connective tissue disease, 
infected pseudoaneurysms, post-traumatic AA and 
peripheral artery diseases. The patient age, gender 
and characteristics were also obtained. The study 
population characteristics are summarised in addi-
tional information Table 1. Samples of human aortic 
tissue were excised from the area of the aneurysm 
during surgery. After excision, we used cold saline to 
store the samples and removed thrombi. The aortic 
specimens were either snap-frozen in liquid nitrogen 
or fixed in 4% formalin until analysis. 
Haematoxylin and eosin staining 
After 48 h in 4% formalin, the tissue samples were 
embedded in paraffin and then sliced into serial aor-
tic sections (3 μm thickness) with a slicing machine 
before being stained with haematoxylin and eosin 
(H&E) and Masson trichrome.
Masson trichrome stain
The fixed aorta samples were dehydrated, and 
paraffin-embedded, and then sectioned at a thickness 
of 3 μm. The sections were used for Masson trichro- 
me staining and were observed with an Olympus 
BX-URA2 camera. 
Western blotting analysis
The frozen aortic tissue samples were homog-
enised, and the proteins were collected and then 
separated by SDS-PAGE. Then, the proteins were 
transferred to polyvinylidene fluoride (PVDF) mem-
branes (Millipore, Billerica, MA, USA), which were 
washed twice for 10 min each in Tris-buffered saline 
(TBS) with Tween® diluted 1:1000 (TBST; Promega, 
Madison, WI, USA) and then blocked with TBS con-
taining 5% non-fat milk powder for 1 h. Next, the 
following primary antibodies were incubated with 
the membranes in TBS with Tween plus 5% milk 
overnight at 4°C: anti-IKKe (1:500; Novus Biologi-
Table 1. Clinical characteristics of the aortic aneurysms  
patients undergoing emergent surgical repair and the control 
group of patients
Item Control group  
(n = 11)
Patients  
(n = 14)
Age [years] 70.0±8.8 69.7 ± 7.7
Sex (male/female) 9/2 11/3
Hypertension 2 (18.2%) 2 (14.2%)
Hyperlipidaemia 5 (45.4%) 4 (28.6%)
Diabetes 2 (18.2%) 3 (21.4%)
Coronary artery disease 1 (9.09%) 0 (0.00%)
Chronic kidney disease 0 (0.00%) 0 (0.00%)
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cals, Littleton, USA), anti-p50 (1:500; Santa Cruz 
Biotechnology, Santa Cruz, CA), anti-GAPDH (1:5000; 
Santa Cruz Biotechnology) and anti-MMP-2 (1:500; 
Abcam). The next day, after washing with TBST four 
times for 10 min each time at room temperature, the 
PVDF membranes were incubated with proportion-
ally diluted peroxidase-conjugated goat anti-rabbit 
secondary antibodies (1:1000; Beijing ZhongShan 
Biotechnology Co.) for 1 h. Furthermore, for the 
specific proteins, we used an ECL reagent (GE Health-
care, Piscataway, NJ, USA) to detect and capture 
images on Hyperfilm (Amersham, GE Healthcare). 
Ultimately, we evaluated the results using Image J 
software [1] for semi-quantitation of the mean grey 
value of each blot. All the details of antibodies are 
in additional information Table 2.
Immunohistochemical staining 
The perfusion-fixed aortas were embedded, cut 
into cross sections (3 μm) and rehydrated in graded 
alcohol for morphological analysis. To prevent the 
non-specific binding of antibodies and to eliminate 
endogenous peroxidase activity, the sections were in-
cubated in buffered normal horse serum and treated 
with 3% hydrogen peroxide for 15 min. Then, we in-
cubated the sections with anti-CD68 (1:200; Abcam), 
anti-P50 (1:100; Santa Cruz), anti-MMP (1:500; Ab-
cam), and anti-IL-6 (1:500; Abcam) primary antibodies 
for 14 h. The sections were incubated with horserad-
ish peroxidase (HRP)-conjugated goat anti-rabbit IgG 
(Beijing Zhongshan Biotechnology Co., Beijing, China) 
for 1 h at 37°C in a humidified box. Subsequently, 
upon application of the substrate diaminobenzidine 
(DAB, Beijing Zhongshan Biotechnology Co.), the 
signal for each antibody appeared. The sections were 
then counterstained, and the differences in these 
signals were determined. As a negative control, the 
primary antibodies were omitted from the reaction 
sequence. The data were recorded using an Olympus 
BX-URA2 camera via photomicrographs. All the details 
of antibodies are in additional information Table 2.
Statistical analysis
All continuous variables are presented as the 
means ± standard errors. Statistical significance was 
defined as a p-value of 0.05. The analyses were per-
formed using SPSS17.0 (SPSS Inc, Chicago, IL, USA) 
software. Categorical variables were compared using 
an independent-sample t test.
RESULTS
Morphological differences of  
the aortic tissue samples 
The results of the H&E staining showed that the 
patients in the AA group had a damaged and thin-
ner medial layer with disordered smooth muscle cells 
and a fibrin clot in the edge between the inner media 
and intima. Furthermore, the entire aortic vessel wall 
showed neutrophil infiltration, particularly in the 
medial layer. By contrast, there was no neutrophil 
infiltration in the control group, and the aortic mor-
phology was normal (Fig. 1A). 
Table 2. The details of antibodies
Antibody name Catalogue 
code
Lot No. Primary/secondary 
antibody
Company The experimental 
subjects
Use for
Anti- IKKe AF3199 Primary antibody Novus Biological Western blot
Anti-P50 sc-114 #H2178 Primary antibody Santa Cruz Human breast tumour Western blot, immunohisto-
chemical staining
Anti-GAPDH sc-25778 Primary  antibody Santa Cruz HeLa cells, human  
lung tissue
Western blot
Anti-MMP2 ab110186 GR52940-7 Primary antibody Abcam Human mammary 
cancer tissue
Western blot, immunohisto-
chemical staining
Goat-anti-rabbit IgG ZB-2301 127760 Secondary antibody ZSGB-BIO Western blot, immunohisto-
chemical staining
Anit-CD68 ab125212 GR77386-17 Primary antibody Abcam Murine spleen tissue Immunohistochemical 
staining
Anti-IL-6 ab6672 GR106735-3 Primary antibody Abcam THP1 cell, human lung, 
mouse mesenchymal 
SC cells
Immunohistochemical 
staining
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The Masson trichrome stain is mainly used for 
the identification of collagen fibres (green) and the 
muscle fibres (red). As it is shown, the collagen of 
the aorta was degraded in the AA group compared 
to the control group (Fig. 1B).
Inflammatory infiltration in AA
To assess inflammatory infiltration, we used im-
munostaining for macrophages (CD68) and the pro-
inflammatory cytokine interleukin 6 (IL-6). Our results 
showed that CD68 and IL-6 were observed through-
out the tunica media at a uniformly distributed den-
sity in the AA group while the control group showed 
no of such expression (Fig. 2). 
Expression of IKKe in AA
Western blot analysis showed a significant differ-
ence in the expression of IKKe (independent t test, 
t = 5.878, df = 18, p < 0.01) between two groups 
(Fig. 3A, B). Similar results were also obtained using 
immunohistochemical staining for IKKe. In addition, 
the area of increased expression of IKKe was primar-
ily in the medial layer of the aortic vessel wall in AA 
patients (Fig. 3C). 
Expression of P50 in AA 
Western blot analysis showed the expression 
of P-P50 (independent t test, t = 10.561, df = 18, 
p < 0.01) was significantly increased in the AA group 
compared to the control group (Fig. 4A). Immunohis-
tochemical staining analysis was used to assess the 
activity and location of P-P50, and the results showed 
that P-P50 was located in the nuclei of stromal cells. 
Figure 1. Morphological changes in the aortic aneurysm (AA) 
group and control group; A. Haematoxylin-eosin staining of the 
aortic vessel wall of AA and the normal aortic media of the control 
group. The integrity of the media was maintained and smooth 
muscle cells were arranged in an orderly fashion in the control 
group. In the aortic vessel wall of the aneurysm group, there were 
disarranged smooth muscle cells in the media, representing the 
infiltration of neutrophils throughout the entire aortic vessel wall, 
particularly in the media (the above are magnification ×100, the 
down are magnification ×400, arrow to indicate the inflammatory 
infiltrations); B. Changes in the extracellular proteins between the 
AA and control groups. Green represents collagen fibres, whereas 
red represents muscle fibres. The collagen of the aorta was  
significantly degraded in the AA group compared to the control 
group (magnification ×400).
Figure 2. Immunohistochemistry staining for interleukin 6 (IL-6) and CD68 showed their increased expression in the aortic aneurysm group 
compared to the control group (magnification ×400).
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These results indicate that the protein is biologically 
active in the AA group (Fig. 4B).
Expression of MMP-2 in AA
To verify the expression and location of MMP-2, 
Western blot analysis and immunostaining were 
used to detect MMP-2. Western blot analysis 
showed that the expression of MMP-2 was signi-
ficantly increased in the AA group compared to 
the control group (independent t test, t = 5.221, 
df = 18, p < 0.01) (Fig. 5A). Immunostaining con-
firmed that MMP-2 was primarily distributed in 
the media in the AA group but not in the control 
group (Fig. 5B).
Figure 3: Protein expression and localisation of IKKe in the aortic aneurysm (AA) group and control group; A. The protein level of IKKe was meas-
ured by Western blotting; a. Western blotting of IKKe and GAPDH; b. The expression of IKKe in the aortic vessel wall after normalisation to GAPDH 
was significantly increased in the AA group compared to the control group. The values are the means ± standard error; *p < 0.01; c. Box-and-
-whisker plots of IKKe; B. Immunohistochemistry staining also showed that IKKe were up-regulated in the AA group when compared with the 
control group, and the expression of IKKe was mainly distributed in the medial area of the aortic vessel wall (magnification ×400). 
Figure 4. Protein expression and localization of P50 determined in the aortic aneurysm (AA) group and control group; A. The protein level 
of P50 was measured by Western blotting; a. Western blotting of P50 and GAPDH; b. The expression of P50 in the aortic vessel wall after 
normalisation to GAPDH was significantly increased in the AA group compared to the control group. The values are the means ± standard 
error; *p < 0.01; c. Box-and-whisker plots of P50; B. Representative images showed the up-regulated expression of P50 in the aorta of the 
AA group compared to the control group, which was spread throughout the entire media and adventitia, particularly in the inner media at the 
border between the intima and media (magnification ×400). 
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DISSCUSION
Aortic aneurysm is a progressive disease of the aorta 
and is mainly associated with smoking, advanced age, 
male sex and atherosclerosis [3]. Existing evidence shows 
that the occurrence of AA is associated with the degrada-
tion of the tunica medial and an inflammatory reaction 
[7, 12]. Histological analysis has shown that the extracel-
lular matrix degeneration is characterised by disruption 
and degradation of medial elastin and gross medial col-
lagen deposition, whereas inflammation is exemplified 
by inflammatory cell infiltration of the aortic wall. We 
observed the same results in our experiment. The integ-
rity of the tunica media was disrupted and there was 
a thinner medial thickness in the AA group, which accom-
panied with main pathological findings of this disease. 
The main pathological characteristics of the ex-
perimental group included neutrophil infiltration and 
disordered of the smooth muscle cells which could 
be observed. In addition, we also detected increased 
infiltration of macrophages by immunohistochemical 
staining for CD68. IL-6 is a downstream factor of the 
nuclear factor-kB cascade, which is secreted at high 
levels in human AA disease [5, 9]. It has also been 
identified as an independent biomarker for severe 
coronary artery disease [2], and is associated with 
the risk of aneurysm rupture [10]. There was a sig-
nificance difference between the AA group and the 
control group in the expression of IL-6, which was 
mainly located in the medial area in the AA group.
IKKe influences nuclear factor-kB signalling and 
induces inflammation, cell proliferation, tumour cell 
survival and cell transformation [14]. A significant 
overexpression of IKKe was observed in the AA group 
compared to the control group. Together with the 
Western blotting results, immunohistochemical stain-
ing showed upregulation of IKKe in the AA group, 
which was distributed particularly in the medial layer. 
These results indicate that the pathological and mor-
phological changes of the AA might be due to the 
upregulation of IKKe.
We assessed changes in P50 in the AA group to de-
termine whether the activation of IKKe promotes AA 
through the activation of P50. Our study demonstrated 
that the expression of total and phosphorylated P50 in 
the aortic vessel wall was increased in the AA group 
compared to the control group, suggesting a role of P50 
in the progression and formation of AA. MMP-2 plays 
an important role in the degradation of extracellular 
proteins and the remodelling of the extracellular matrix. 
The expression of MMP-2 was significantly increased in 
the AA group compared to the control group.
In this study, immunohistochemistry was used 
to visualise the localisation of IKKe, P50 and MMP-2. 
Our results revealed that IKKe, P50 and MMP-2 were 
upregulated in the aortic tissue of the AA group 
compared to the control group. 
Based on these results, our study suggests that 
the expression of IKKe and P50 signalling may regu-
Figure 5. Protein expression, localisation and activity of MMP-2 in the aortic aneurysm (AA) and control groups; A. The protein level of MMP-2 
was measured by Western blotting; a. Western blotting of MMP-2; b. The expression level of MMP-2 in the aortic vessel wall after normalisa-
tion to GAPDH was significantly increased in the AA group compared to the control group. The values are the means ± standard error;  
*p < 0.01; c. Box-and-whisker plots of MMP-2; B. The representative images show the upregulated expression of MMP-2 in the aorta of the 
AA group compared to the control group, which was spread throughout the entire media and adventitia, particularly in the inner media at the 
border between the intima and media (magnification ×400).
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late the transcription of diverse genes encoding 
cytokines (IL-6), which could lead to the infiltration 
of macrophages and the secretion of MMPs. Moreo-
ver, the extracellular matrix of the medial layer was 
degenerated, which resulted in the formation of the 
AA. This study also provides us a deeper insight of 
the AAs at the molecular level, which may lead to 
a better understanding and future treatment and 
also prevention of patients with AA through the 
inhibition of IKKe.
CONCLUSIONS
The over-expression of IKKe may play an important 
role in the origination and progression of AA and 
might be a vital target for their treatment.
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